SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-035632
Filing Date
2007-05-04
Accepted
2007-05-03 19:50:37
Documents
15
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a07-10703_110q.htm 10-Q 961957
2 EX-10.1 a07-10703_1ex10d1.htm EX-10.1 13323332
3 EX-12.1 a07-10703_1ex12d1.htm EX-12.1 41848
4 EX-31.1 a07-10703_1ex31d1.htm EX-31.1 14205
5 EX-31.2 a07-10703_1ex31d2.htm EX-31.2 12222
6 EX-32.1 a07-10703_1ex32d1.htm EX-32.1 6575
7 EX-32.2 a07-10703_1ex32d2.htm EX-32.2 6556
8 GRAPHIC g107032ka47i001.gif GRAPHIC 2485
9 GRAPHIC g107032ka23i001.gif GRAPHIC 3244
10 GRAPHIC g107032ka35i001.jpg GRAPHIC 85079
11 GRAPHIC g107032ka35i002.jpg GRAPHIC 1989
12 GRAPHIC g107032ka35i003.jpg GRAPHIC 2169
13 GRAPHIC g107032ka15i001.jpg GRAPHIC 1958
14 GRAPHIC g107032ka39i001.gif GRAPHIC 2485
15 GRAPHIC g107032ka31i001.jpg GRAPHIC 2477
  Complete submission text file 0001104659-07-035632.txt   14509697
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 07817408
SIC: 2834 Pharmaceutical Preparations